Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 9/20 | 0.38 |
| ▸ | SMYD3 | Q9H7B4 | 4/20 | 0.38 |
| ▸ | HTR1A | P08908 | 2/20 | 0.35 |
| ▸ | HTR7 | P34969 | 2/20 | 0.35 |
| ▸ | PDE3B | Q13370 | 2/20 | 0.34 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.34 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6997272 | 0.95 | PARP1 (0.37) | PARP1SMYD3HTR1AHTR7PDE3B | |
| SCHEMBL6997632 | 0.87 | PARP1 (0.42) | PARP1SMYD3HTR1AHTR7PDE3B | |
| SCHEMBL7000036 | 0.84 | NR3C1 (0.33) | NR3C1 | |
| SCHEMBL6998308 | 0.80 | PARP1 (0.46) | PARP1SMYD3HTR1AHTR7PDE3B | |
| SCHEMBL6991269 | 0.76 | PARP1 (0.40) | PARP1SMYD3HTR1AHTR7PDE3B | |
| SCHEMBL6998306 | 0.76 | PARP1 (0.40) | PARP1SMYD3HTR1AHTR7PDE3B | |
| SCHEMBL7000925 | 0.75 | PARP1 (0.42) | PARP1SMYD3 | |
| SCHEMBL6999457 | 0.74 | PARP1 (0.42) | PARP1SMYD3 | |
| SCHEMBL6996238 | 0.74 | PARP1 (0.41) | PARP1SMYD3HTR1AHTR7PDE3B | |
| SCHEMBL6995026 | 0.74 | PARP1 (0.38) | PARP1SMYD3HTR1AHTR7PDE3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1015437-B1 | BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS | SCHERING AG (DE) | 2003-12-03 | — | — | EP | disclosed |